Cetera Investment Advisers
MBOT icon

Cetera Investment Advisers’s Microbot Medical MBOT Stock Holding History

Cetera Investment Advisers’s Portfolio MBOT Stock Details MBOT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$102K Buy
42,412
+13,099
+45% +$29.3K ﹤0.01% 4445
2025
Q4 		$58.6K Buy
29,313
+8,201
+39% +$19.4K ﹤0.01% 4486
2025
Q3 		$64.4K Buy
+21,112
New +$65.8K ﹤0.01% 4401

Other funds holding MBOT

VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
CBU
CIBC Bancorp USA Chicago, Illinois $74.4B AUM
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
DnB Asset Management
DnB Asset Management Oslo, Norway $28B AUM 26% 1-Year Est. Return
Stifel Financial
Stifel Financial St. Louis, Missouri $109B AUM 21.36% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
AA
Ancora Advisors Cleveland, Ohio $4.7B AUM 19.05% 1-Year Est. Return

Cetera Investment Advisers's MBOT Position: Q1 2026 in Review

Cetera Investment Advisers increased its Microbot Medical (MBOT) stake by 45% in Q1 2026, buying an estimated $29.3K and bringing the position to 42,412 shares worth $102K. The position accounts for ﹤0.01% of the portfolio, ranked #4445.

Cetera Investment Advisers first reported a position in MBOT in Q3 2025 and has held it in 3 quarters since. 79 funds tracked by Wall St. Rank hold MBOT as of Q1 2026.

  • Cetera Investment Advisers held 42,412 shares of Microbot Medical worth $102K as of Q1 2026.
  • Cetera Investment Advisers bought 13,099 Microbot Medical shares in Q1 2026, an estimated $29.3K.
  • Microbot Medical made up ﹤0.01% of Cetera Investment Advisers's portfolio in Q1 2026, its #4445 holding.
  • Cetera Investment Advisers first reported a position in Microbot Medical in Q3 2025 and has held it in 3 quarters since.
  • 79 funds tracked by Wall St. Rank held Microbot Medical as of Q1 2026.

Based on Cetera Investment Advisers's 13F filing for Q1 2026, filed 13 May 2026.